Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model.
Paris L, Podo F, Spadaro F, Abalsamo L, Pisanu ME, Ricci A, Cecchetti S, Altabella L, Buoncervello M, Lozneanu L, Bagnoli M, Ramoni C, Canevari S, Mezzanzanica D, Iorio E, Canese R.
Paris L, et al. Among authors: ramoni c.
Oncotarget. 2017 Jul 5;8(33):55022-55038. doi: 10.18632/oncotarget.18992. eCollection 2017 Aug 15.
Oncotarget. 2017.
PMID: 28903399
Free PMC article.